Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 9/14/2014
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Alopecia, Asthenia, Fatigue, Skin papilloma, Emotional distress
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES1408USA008872
Write-up:This spontaneous report was received from patient''s mother via company representative refers to a 11 year old male patient. Medical history was not reported. In September 2013 the patient was vaccinated with the first dose of GARDASIL the second dose was administered in November 2013 and the third dose was administered on 27-MAR-2014, the lot number, expiration date, strength and route were not reported for all of them. Concomitant therapy was not reported. The consumer informed that approximately on 10-APR-2014 (also reported as two weeks after the third dose) her son felt weak and fatigued and patches of his hair began to fall out. Also informed that she took her son to see a dermatologist who diagnosed her son with alopecia. A topical ointment was used on the patient''s scalp to prevent further hair loss, therefore the patient began receiving shots in his scalp. The consumer also stated that on approximately August 2014, her son just got three warts on his hand and he was still tired, which was causing him significant distress. The reporter considered that the events caused significant disability or incapacity to the patient. The outcome of the events was not recovered. Additional information is not expected because the reporter refuse the contact with the physician.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166